4//SEC Filing
Halladay Benjamin 4
Accession 0001628280-24-011488
CIK 0001434868other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 4:32 PM ET
Size
20.0 KB
Accession
0001628280-24-011488
Insider Transaction Report
Form 4
Halladay Benjamin
Chief Financial Officer
Transactions
- Award
Common Stock
2024-03-14+170,000→ 243,936 total - Award
Stock Option (right to buy)
2024-03-14+200,000→ 200,000 totalExercise: $2.05Exp: 2034-03-14→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be June 15, 2024.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0001953943
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 4:32 PM ET
- Size
- 20.0 KB